0102030405
GLECAPREVIR Intermediates CAS No 1365970-48-4 Pharmaceutical Intermediates
02
introduce
(33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxaline-3(3,1)-pyrrolidine-9(1,2)-cyclopentane-tetradec-12-ene-35-carboxylic acid is a highly specialized compound designed for the pharmaceutical industry. The compound has a complex molecular structure that contributes to its unique properties, making it an essential ingredient in drug development and formulation. As a factory integrating production and trading, we ensure that our products meet the highest standards of quality and efficacy.
02
Physical and chemical properties
The compound possesses a range of physical and chemical properties that enhance its suitability for a variety of pharmaceutical applications:
- Molecular formula: C29H34F2N4O7
- Molecular weight: 588.6 g/mol
- Appearance: White to Off-White solid
- Solubility: Soluble in organic solvents such as DMSO and methanol; limited solubility in water
- Stability: Stable under standard storage conditions; should be protected from light and moisture to maintain its integrity.
- Melting point: approx. 150-155°C
The presence of difluoro and dioxy groups enhances the stability and reactivity of the compound, making it a valuable intermediate for the synthesis of various drugs. The unique structure enables it to interact specifically with biological targets, which is expected to bring innovative therapeutic applications.
1. Enhanced Bioavailability: The innovative chemical structure of this compound is designed to increase absorption and bioavailability, making it more effective in therapeutic applications.
2. Targeting: Specific molecular structures allow for targeted effects within biological systems, potentially improving therapeutic efficacy.
3. Widely used: The compound can be used in a variety of pharmaceutical formulations, including oral, injectable and topical, making it a versatile choice for researchers and manufacturers.
4. Research and Development: This compound is well suited for use in a research and development setting, enabling the development of new drugs and therapies, particularly in the areas of oncology and neurology.
5. Regulatory Compliance: Our products adhere to all relevant regulatory standards, ensuring they are safe and effective in pharmaceutical applications.
(33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxaline-3(3,1)-pyrrolidine-9(1,2)-cyclopentane-12-ene-35-carboxylic acid is a premium compound that stands out in the pharmaceutical industry for its unique properties and benefits. With its high purity, high bioavailability and versatility, it is an essential ingredient for pharmaceutical companies seeking to innovate and improve their product offerings.
Our commitment to quality and regulatory compliance ensures you receive products that meet the highest standards. Partner with us for your pharmaceutical needs and experience the benefits of our advanced chemistry solutions. For more information or to place an order, contact us today!
By choosing (33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxaline-3(3,1)-pyrrolidine-9(1,2)-cyclopentanecyclotetradec-12-ene-35-carboxylic acid, you are investing in a product that not only meets but exceeds the expectations of the pharmaceutical industry, paving the way for innovative therapeutic solutions. Our extensive experience in manufacturing and trading ensures that you receive a reliable and effective product tailored to your specific needs.